Lataa...
Renal effects of a sodium‐glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status
AIMS: Little is known about whether sodium intake is associated with the clinical effects of SGLT2 inhibitors (SGLT2is); however, SGLT2is may increase urinary sodium excretion. Thus, we investigated the impact of daily sodium intake on the estimated glomerular filtration rate (eGFR) via an SGLT2i, t...
Tallennettuna:
| Julkaisussa: | Diabetes Obes Metab |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6619387/ https://ncbi.nlm.nih.gov/pubmed/30945431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13731 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|